Digital Health has become one of the most widely used terms associated with the clinical workflow and business processes critical to improving patient outcomes and the financial performance of the healthcare industry.
Frost & Sullivan’s Digital Health Research Program
The Digital Health team utilizes a proven methodology that leverages Frost & Sullivan’s proprietary forecast models, access to high-quality internal and external published content, and information gained from primary research interviews. The Digital Health team provides the content that goes well beyond the basic news that everyone can access.
Frost & Sullivan’s expertise in digital health research and consulting includes work in the following strategic and operational areas:
Population Health Management (PHM)
PHM as a concept it offers to potential to achieve a tangible reduction of disease risk. PHM can relieve the financial burden associated with accessing healthcare at a population level. The execution of the concept will result in an intricate interaction between telehealth technologies, software solutions, and healthcare services. The digital health team is heavily focused on the suppliers, applications and users of PHM solutions.
Artificial Intelligence (AI)
AI offers great promise in a variety of data-driven segments of healthcare. Significant growth opportunities will be available in areas, such as: Clinical-grade AI applications that advance predictive analytics, medical diagnosis, and clinical documentation. AI-driven advances will be increasingly visible across the healthcare market including a strong potential for interactive virtual assistants to improve both the patient experience and the clinicians operational workflow.
Internet of Medical Things (IoMT)
Technologies such as virtual visits, remote patient monitoring (RPM), mobile health (mHealth), and personal emergency response systems (PERS) have enabled patients to leave the hospital sooner because their chronic or post-acute conditions can be tracked and addressed regardless of their location. Telehealth is also able to help providers penalties associated with hospital readmissions due to chronic conditions.
Electronic Health Records (EHRs)
The EHR market is of importance to technology vendors, health care providers, and payers. In addition to covering the latest features, functions, technology platforms for hospital EHRs the digital health team assesses the future capabilities that will expand EHR functionality, content, and interoperability as EHRs expand their functionality and reach to all healthcare stakeholders.
Digital Workflow Solutions
Healthcare providers are utilizing healthcare information technologies (HCIT) in a variety of ways to improve the operational and clinical workflow. EHRs are adding content, functionality as new technologies improve the way that physicians can work with these tools. Interactive patients can easily schedule appointments, access personal data and perform other functions via their smartphone, tablets, or wearables.
Book a complimentary one-hour Growth Pipeline Dialog™ session with our Healthcare & Life Sciences experts.
Greg Caressi is responsible for Frost & Sullivan’s Healthcare and Life Sciences practice, which includes Digital Health, Life Sciences, Medical Imaging & Informatics, and Advanced Medical Technologies. He engages with industry leaders across the globe regarding their technology needs and gaps, and leverages insights from our research to identify growth opportunities and needed solution capabilities for healthcare stakeholders, including healthcare providers, payors, government agencies, medical technology vendors and individual consumers.
Reenita Das currently serves as Healthcare and Life Sciences’ Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan, driving the global research vision and strategy for the firm as well as commercial opportunities within the healthcare practice. She has lived and worked in over 10 countries in the world, focusing on finding solutions to healthcare challenges and implementing growth change strategies. She recently got voted the top 100 women in Femtech and Healthtech. Reenita’s focus is on how healthcare will operate 20 years from today and she shares her vision at leading conferences and events.
She is also passionate about using digital solutions and creating gender-specific healthcare by her focus on “Femtech” and the growth opportunities from this new sector which includes advising companies on the right strategies and commercial business models to success.
Dinesh Sampath Rangaraj
With more than 24 years of industry experience, Nitin serves as Frost & Sullivan’s Global Practice Area Leader (HLS). In this role, he is dedicated to executing strategy consulting, forecasting analytics, commercial due diligence and clinical R&D projects for healthcare companies.
Nitin has a strong understanding of the dynamics in the healthcare industry and possesses domain knowledge in the life sciences space. He has advised several mid sized companies and start-ups in numerous commercial transactions and IPOs to optimize market positioning and valuation strategies.
He has led strategic initiatives with Medical Device & Life Science companies:
- Emerging markets go to market strategy , Innovative therapies portfolio analysis
- Sales, Marketing, Distribution planning
- Global Alliances, Public Private Partnerships, M&A.
- Co-innovation programs, research
Charlie leads Frost & Sullivan’s growth consulting practice in the Americas supporting clients across the healthcare technology and services ecosystem. His responsibilities include project management, business development, strategic planning and subject matter expertise, particularly in the medical devices market.
Siddharth (Sid) Shah leads the global medtech research program of the Healthcare & Life Sciences practice, and has over ten years of healthcare market research & consulting experience. In his prior life he has also conducted wet lab research in stem cells at the prestigious Johns Hopkins University. Beyond medical devices, Shah also tracks innovations in radiology artificial intelligence, diabetes, and connected devices. He holds a Master of Science in Biotechnology from the Johns Hopkins University.
Daniel leads the growth consulting practice for Healthcare & Life Sciences in the Middle East & Africa. This practice covers Healthcare Delivery & Operations, Medical Imaging & Informatics, Pharmaceuticals & Life Sciences, and Digital Health.
Daniel is a seasoned healthcare professional with more than 15 years’ experience in the healthcare industry and has extensive experience supporting clients to achieve their strategic growth objectives through Optimization, Efficiency, Quality and Cost Initiatives; Market Analysis, Customer VOC/Perception studies, Due Diligence, and Service Expansion; Healthcare Data and Analytics; Change, Program and Project Management; and, Leadership Development.
Imran has over 20 years of experience in market research and consulting, covering a range of information and communication technologies across multiple industry verticals and enterprise and consumer segments.